Rosiglitazone attenuates the metalloprotease/anti-metalloprotease imbalance in emphysema induced by cigarette smoke: involvement of extracellular signal-regulated kinase and NFκB signaling

References

• VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• AngelisNPorpodisKZarogoulidisPAirway inflammation in chronic obstructive pulmonary diseaseJ Thorac Dis20146Suppl 1S167S17224672691
   PubMed Web of Science ®Google Scholar
• MocchegianiEGiacconiRCostarelliLMetalloproteases/anti-metalloproteases imbalance in chronic obstructive pulmonary disease: genetic factors and treatment implicationsCurr Opin Pulm Med201117Suppl 1S11S1922209925
   PubMed Web of Science ®Google Scholar
• ChurgAZhouSWrightJLSeries “matrix metalloproteinases in lung health and disease”: matrix metalloproteinases in COPDEur Respir J201239119720921920892
   PubMed Web of Science ®Google Scholar
• DhariwalJTennantRCHansellDMSmoking cessation in COPD causes a transient improvement in spirometry and decreases micronodules on high-resolution CT imagingChest201414551006101524522562
   PubMed Web of Science ®Google Scholar
• CoxsonHODirksenAEdwardsLDEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsThe presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE studyLancet Respir Med20131212913624429093
   PubMed Web of Science ®Google Scholar
• CarolanBJSutherlandERClinical phenotypes of chronic obstructive pulmonary disease and asthma: Recent advancesJ Allergy Clin Immunol2013131362763423360757
   PubMed Web of Science ®Google Scholar
• AhmadianMSuhJMHahNPPARγ signaling and metabolism: the good, the bad and the futureNat Med201319555756623652116
   PubMed Web of Science ®Google Scholar
• KostadinovaRWahliWMichalikLPPARs in diseases: control mechanisms of inflammationCurr Med Chem200512252995300916378501
   PubMed Web of Science ®Google Scholar
• BelvisiMGHeleDJBirrellMAPeroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammationEur J Pharmacol20065331–310110916458290
   PubMed Web of Science ®Google Scholar
• YooSHAbdelmegeedMASongBJActivation of PPARalpha by Wy-14643 ameliorates systemic lipopolysaccharide-induced acute lung injuryBiochem Biophys Res Commun2013436336637123727576
   PubMed Web of Science ®Google Scholar
• LuXBijliKMRamirezAMurphyTCKleinhenzJHartCMHypoxia downregulates PPARgamma via an ERK1/2-NF-kappaB-Nox4-dependent mechanism in human pulmonary artery smooth muscle cellsFree Radic Biol Med20136315116023684777
   PubMed Web of Science ®Google Scholar
• WechslerMELavioletteMRubinASAsthma Intervention Research 2 Trial Study GroupBronchial thermoplasty: long-term safety and effectiveness in patients with severe persistent asthmaJ Allergy Clin Immunol201313261295130223998657
   PubMed Web of Science ®Google Scholar
• KimSHHongJHLeeYCUrsolic acid, a potential PPARgamma agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthmaEur J Pharmacol20137011–313114323201068
   PubMed Web of Science ®Google Scholar
• LeaSPlumbJMetcalfeHThe effect of peroxisome proliferator-activated receptor-gamma ligands on in vitro and in vivo models of COPDEur Respir J201443240942023794466
   PubMed Web of Science ®Google Scholar
• YamasakiSNakashimaTKawakamiAFunctional changes in rheumatoid fibroblast-like synovial cells through activation of per-oxisome proliferator-activated receptor gamma-mediated signalling pathwayClin Exp Immunol2002129237938412165097
   PubMed Web of Science ®Google Scholar
• KoGJKangYSHanSYPioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic ratsNephrol Dial Transplant20082392750276018388116
   PubMed Web of Science ®Google Scholar
• MiyaharaTSchrumLRippeRPeroxisome proliferator-activated receptors and hepatic stellate cell activationJ Biol Chem200027546357153572210969082
   PubMed Web of Science ®Google Scholar
• XuLCaiBQZhuYJPathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in ratsChin Med J (Engl)2004117111611161915569474
   PubMed Web of Science ®Google Scholar
• QiBChenHLShangDDongYZhangGXYuLEffects of hypoxia-inducible factor-1alpha and matrix metalloproteinase-9 on alveolar-capillary barrier disruption and lung edema in rat models of severe acute pancreatitis-associated lung injuryExp Ther Med2014889990625120621
   PubMed Web of Science ®Google Scholar
• GonzalezRFDobbsLGIsolation and culture of alveolar epithelial Type I and Type II cells from rat lungsMethods Mol Biol201394514515923097106
   PubMedGoogle Scholar
• MocchegianiEGiacconiRCostarelliLMetalloproteases/anti-metalloproteases imbalance in chronic obstructive pulmonary disease: genetic factors and treatment implicationsCurr Opin Pulm Med201117Suppl 1S11S1922209925
   PubMed Web of Science ®Google Scholar
• AntunesMARoccoPRElastase-induced pulmonary emphysema: insights from experimental modelsAn Acad Bras Cienc20118341385139622159348
   PubMed Web of Science ®Google Scholar
• NavratilovaZZatloukalJKriegovaEKolekVPetrekMSimultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary diseaseRespirology20121761006101222591289
   PubMed Web of Science ®Google Scholar
• YinYHouGLiERWangQYKangJRegulation of cigarette smoke-induced toll-like receptor 4 expression by peroxisome proliferator-activated receptor-gamma agonists in bronchial epithelial cellsRespirology201318Suppl 3303924188201
   PubMed Web of Science ®Google Scholar
• HetzelMWalcherDGrübMBachHHombachVMarxNInhibition of MMP-9 expression by PPARgamma activators in human bronchial epithelial cellsThorax200358977878312947137
   PubMed Web of Science ®Google Scholar
• MarxNFroehlichJSiamLAntidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery diseaseArterioscler Thromb Vasc Biol200323228328812588772
   PubMed Web of Science ®Google Scholar
• HanLLiMGLiuYXHanCGYePAtorvastatin may delay cardiac aging by upregulating peroxisome proliferator-activated receptors in ratsPharmacology2012891–2748222343316
   PubMed Web of Science ®Google Scholar
• KobayashiYWadaHRossiosCA novel macrolide solithromycin exerts superior anti-inflammatory effect via NF-kappaB inhibitionJ Pharmacol Exp Ther20133451768423359665
   PubMed Web of Science ®Google Scholar
• BrownVElbornJSBradleyJEnnisMDysregulated apoptosis and NFkappaB expression in COPD subjectsRespir Res2009102419296848
   PubMed Web of Science ®Google Scholar
• SuzawaMTakadaIYanagisawaJCytokines suppress adipogenesis and PPAR-function through the TAK1/TAB1/NIK cascadeNat Cell Biol20035322423012598905
   PubMed Web of Science ®Google Scholar
• KellyDCampbellJIKingTPCommensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelANat Immunol20045110411214691478
   PubMed Web of Science ®Google Scholar
• KaplanJNowellMChimaRZingarelliBPioglitazone reduces inflammation through inhibition of NF-kappa B in polymicrobial sepsisInnate Immun201420551952824029145
   PubMed Web of Science ®Google Scholar
• MaoJLiuJPangXNicotine induces the expression of C-reactive protein via MAPK-dependent signal pathway in U937 macrophagesMol Cells201234545746123149874
   PubMed Web of Science ®Google Scholar
• BurgermeisterESegerRMAPK kinases as nucleo-cytoplasmic shuttles for PPAR gammaCell Cycle20076131539154817611413
   PubMed Web of Science ®Google Scholar
• BurnsKAVanden HeuvelJPModulation of PPAR activity via phosphorylationBiochim Biophys Acta20071771895296017560826
   PubMed Web of Science ®Google Scholar
• KimEJParkKSChungSYPeroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta(12,14)-prostaglandin J(2) inhibits neuroblastoma cell growth through induction of apoptosis: Association with extracellular signal-regulated kinase signal pathwayJ Pharmacol Exp Ther2003307250551712966153
   PubMed Web of Science ®Google Scholar
• LombardiACantiniGPiscitelliEA new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cellsArterioscler Thromb Vasc Biol200828471872418239149
   PubMed Web of Science ®Google Scholar
• BaiYPLiuYHChenJRosiglitazone attenuates NF-kappaB-dependent ICAM-1 and TNF-alpha production caused by homocysteine via inhibiting ERK1/2/p38MAPK activationBiochem Biophys Res Commun20073601202617583675
   PubMed Web of Science ®Google Scholar
• KaplanJMHakePWDenenbergANowellMPirainoGZingarelliBPhosphorylation of extracellular signal-regulated kinase (ERK)-1/2 Is associated with the downregulation of peroxisome proliferator-activated receptor (PPAR)-γ during polymicrobial sepsisMol Med20101611–1249149720809049
   PubMed Web of Science ®Google Scholar
• MoonHSGuoDDLeeHGAlpha-eleostearic acid suppresses proliferation of MCF-7 breast cancer cells via activation of PPARgamma and inhibition of ERK 1/2Cancer Sci2010101239640219917060
   PubMed Web of Science ®Google Scholar
• LiMLeeTWMokTSWarnerTDYimAPChenGGActivation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growthJ Cell Biochem200596476077416149072
   PubMed Web of Science ®Google Scholar